1. Home
  2. CTKB vs MAGN Comparison

CTKB vs MAGN Comparison

Compare CTKB & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • MAGN
  • Stock Information
  • Founded
  • CTKB 1990
  • MAGN 1864
  • Country
  • CTKB United States
  • MAGN United States
  • Employees
  • CTKB N/A
  • MAGN N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MAGN Paper
  • Sector
  • CTKB Health Care
  • MAGN Basic Materials
  • Exchange
  • CTKB Nasdaq
  • MAGN Nasdaq
  • Market Cap
  • CTKB 718.8M
  • MAGN 681.5M
  • IPO Year
  • CTKB 2021
  • MAGN N/A
  • Fundamental
  • Price
  • CTKB $4.00
  • MAGN $18.28
  • Analyst Decision
  • CTKB Buy
  • MAGN Buy
  • Analyst Count
  • CTKB 2
  • MAGN 1
  • Target Price
  • CTKB $7.00
  • MAGN $24.00
  • AVG Volume (30 Days)
  • CTKB 957.9K
  • MAGN 387.2K
  • Earning Date
  • CTKB 05-07-2025
  • MAGN 04-08-2025
  • Dividend Yield
  • CTKB N/A
  • MAGN N/A
  • EPS Growth
  • CTKB N/A
  • MAGN N/A
  • EPS
  • CTKB N/A
  • MAGN N/A
  • Revenue
  • CTKB $200,453,000.00
  • MAGN $2,370,000,000.00
  • Revenue This Year
  • CTKB $6.66
  • MAGN $55.60
  • Revenue Next Year
  • CTKB $9.54
  • MAGN $4.32
  • P/E Ratio
  • CTKB N/A
  • MAGN N/A
  • Revenue Growth
  • CTKB 3.85
  • MAGN N/A
  • 52 Week Low
  • CTKB $3.98
  • MAGN $15.86
  • 52 Week High
  • CTKB $7.63
  • MAGN $26.78
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 32.03
  • MAGN N/A
  • Support Level
  • CTKB $4.03
  • MAGN N/A
  • Resistance Level
  • CTKB $4.41
  • MAGN N/A
  • Average True Range (ATR)
  • CTKB 0.18
  • MAGN 0.00
  • MACD
  • CTKB 0.03
  • MAGN 0.00
  • Stochastic Oscillator
  • CTKB 4.21
  • MAGN 0.00

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About MAGN Magnera Corporation Common Stock

Magnera Corp formerly Glatfelter Corporation manufactures and sells a variety of paper and fiber products. The company's reportable segments are; Composite Fibers, Spunlace. and Airlaid Materials. The Airlaid Materials segment which is also its key revenue generating segment, is a supplier of cellulose-based airlaid nonwoven materials used to manufacture consumer products for end-user markets. The Airlaid Materials segment produces materials used in feminine hygiene, specialty wipes, tabletop, home care, and other consumables. Geographically, the company derives majority of its revenue from Americas and rest from Europe, Middle East, Africa and Asia Pacific markets.

Share on Social Networks: